SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin gains on reporting 26% rise in Q3 consolidated net profit

05 Feb 2015 Evaluate

Lupin is currently trading at Rs. 1590.00, up by 11.35 points or 0.72% from its previous closing of Rs. 1578.65 on the BSE.

The scrip opened at Rs. 1585.00 and has touched a high and low of Rs. 1601.00 and Rs. 1577.30 respectively. So far 28715 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1606.00 on 02-Feb-2015 and a 52 week low of Rs. 890.00 on 13-Feb-2014.

Last one week high and low of the scrip stood at Rs. 1606.00 and Rs. 1520.55 respectively. The current market cap of the company is Rs. 71531.38 crore.

The promoters holding in the company stood at 46.66% while Institutions and Non-Institutions held 42.51% and 10.83% respectively.

Lupin has reported a fall of 3.76% in its net profit after tax at Rs 513.3 crore for the quarter under review as compared to Rs 533.38 crore for the same quarter in the previous year. Total income of the company has decreased 1.01% at Rs 2406.03 crore for Q3FY15 as compared Rs 2430.56 crore for the corresponding quarter previous year.

On the consolidated basis the company’s net profit after tax rose 26.32% to Rs 601.45 crore for the Q3 FY15 as compared to Rs 476.13 crore in Q3 FY14. Moreover, the total income increased 6.76% to Rs 3261.04 crore in the quarter under review as compared to Rs 3054.41 crore in the corresponding quarter previous year.

 

Lupin Share Price

2324.25 -2.25 (-0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×